Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
SaleCommon Stock | 4,438 | $54.00 | $239,652.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 7 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,439 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:06 UTC |
GEMAYEL GEORGESDirector
|
Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 7,905 | $0.00 Strike: $25.30 | $0.00 |
DisclosureSEC source: 0001256088-26-000006 · wk-form4_1773086807.xml · derivative · entry 4 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,905 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:06 UTC |
GEMAYEL GEORGESDirector
|
SaleCommon Stock | 8,787 | $53.00 | $465,711.00 |
DisclosureSEC source: 0001256088-26-000006 · wk-form4_1773086807.xml · nonDerivative · entry 3 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,277 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.03. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:06 UTC |
GEMAYEL GEORGESDirector
|
Exercise / conversionCommon Stock | 7,905 | $25.30 | $199,996.50 |
DisclosureSEC source: 0001256088-26-000006 · wk-form4_1773086807.xml · nonDerivative · entry 2 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000010 · wk-form4_1773173598.xml · derivative · entry 4 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F2 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Tax withholdingCommon Stock | 1,793 | $54.73 | $98,130.89 |
DisclosureSEC source: 0001804567-26-000010 · wk-form4_1773173598.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,063 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000010 · wk-form4_1773173598.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Exercise / conversionPerformance Share Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000010 · wk-form4_1773173570.xml · derivative · entry 6 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F2 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Exercise / conversionPerformance Share Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000010 · wk-form4_1773173570.xml · derivative · entry 5 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F2 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 1,450 | $54.73 | $79,358.50 |
DisclosureSEC source: 0001194020-26-000010 · wk-form4_1773173570.xml · nonDerivative · entry 4 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,232 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000010 · wk-form4_1773173570.xml · nonDerivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 1,433 | $54.73 | $78,428.09 |
DisclosureSEC source: 0001194020-26-000010 · wk-form4_1773173570.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,682 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000010 · wk-form4_1773173570.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionPerformance Share Unit · Derivative | 38,640 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001539937-26-000006 · wk-form4_1773173627.xml · derivative · entry 4 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,640 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F2 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Khattar Jack A.Director · President, CEO
|
Tax withholdingCommon Stock | 16,574 | $54.73 | $907,095.02 |
DisclosureSEC source: 0001539937-26-000006 · wk-form4_1773173627.xml · nonDerivative · entry 2 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,228,644 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Khattar Jack A.Director · President, CEO
|
Exercise / conversionCommon Stock | 38,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001539937-26-000006 · wk-form4_1773173627.xml · nonDerivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,245,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Exercise / conversionPerformance Share Unit · Derivative | 1,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · derivative · entry 11 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F2 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Exercise / conversionPerformance Share Unit · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · derivative · entry 10 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F2 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Exercise / conversionPerformance Share Unit · Derivative | 2,625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · derivative · entry 9 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F2 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Tax withholdingCommon Stock | 521 | $54.73 | $28,514.33 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 6 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,877 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Exercise / conversionCommon Stock | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 5 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Tax withholdingCommon Stock | 1,718 | $54.73 | $94,026.14 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 4 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,273 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 3 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Tax withholdingCommon Stock | 1,216 | $54.73 | $66,551.68 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 2 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,241 F1 · kind: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:12 UTC |
Horich William ToddSVP, Commercial Operations
|
Exercise / conversionCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0002117599-26-000004 · wk-form4_1773173526.xml · nonDerivative · entry 1 Horich William Todd · CIK 0002117599 · SVP, Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 20:06 UTC |
GEMAYEL GEORGESDirector
|
SaleCommon Stock | 10,000 | $53.71 | $537,100.00 |
DisclosureSEC source: 0001256088-26-000006 · wk-form4_1773086807.xml · nonDerivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,159 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.50 to $54.15. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 21:09 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantPerformance Share Unit · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000008 · wk-form4_1772572184.xml · derivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires not disclosed F1 · derivative.exercise_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. F1 · derivative.expiration_date: On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 21:11 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantPerformance Share Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000008 · wk-form4_1772572265.xml · derivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F1 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 21:11 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantPerformance Share Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000008 · wk-form4_1772572265.xml · derivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F1 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 21:12 UTC |
Khattar Jack A.Director · President, CEO
|
GrantPerformance Share Unit · Derivative | 38,640 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001539937-26-000004 · wk-form4_1772572321.xml · derivative · entry 1 Khattar Jack A. · CIK 0001539937 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,640 Underlying: Common Stock · 38,640 shares Expires not disclosed F1 · derivative.exercise_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. F1 · derivative.expiration_date: On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:17 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000006 · wk-form4_1772140659.xml · derivative · entry 3 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:17 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 675 | $50.69 | $34,215.75 |
DisclosureSEC source: 0001836067-26-000006 · wk-form4_1772140659.xml · nonDerivative · entry 2 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,341 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:17 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000006 · wk-form4_1772140659.xml · nonDerivative · entry 1 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,016 Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:19 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000006 · wk-form4_1772140796.xml · derivative · entry 3 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,875 Underlying: Common Stock · 1,875 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:19 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
Tax withholdingCommon Stock | 977 | $50.69 | $49,524.13 |
DisclosureSEC source: 0001804567-26-000006 · wk-form4_1772140796.xml · nonDerivative · entry 2 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,106 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:19 UTC |
Mottola FrankSVP, Chief Tech. Ops. Officer
|
GrantCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001804567-26-000006 · wk-form4_1772140796.xml · nonDerivative · entry 1 Mottola Frank · CIK 0001804567 · SVP, Chief Tech. Ops. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,083 Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:19 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Disposition to issuerRestricted Stock Unit · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000006 · wk-form4_1772140756.xml · derivative · entry 3 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:19 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
Tax withholdingCommon Stock | 1,279 | $50.69 | $64,832.51 |
DisclosureSEC source: 0001194020-26-000006 · wk-form4_1772140756.xml · nonDerivative · entry 2 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,115 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:19 UTC |
DEC TIMOTHY CSenior Vice-President & CFO
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001194020-26-000006 · wk-form4_1772140756.xml · nonDerivative · entry 1 DEC TIMOTHY C · CIK 0001194020 · Senior Vice-President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,394 Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:18 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000006 · wk-form4_1772140700.xml · derivative · entry 3 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:18 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
Tax withholdingCommon Stock | 650 | $50.69 | $32,948.50 |
DisclosureSEC source: 0001539215-26-000006 · wk-form4_1772140700.xml · nonDerivative · entry 2 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,044 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 25, 2026 Filed Feb 26, 2026 21:18 UTC |
Bhatt Padmanabh P.Sr. VP of IP, CSO
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001539215-26-000006 · wk-form4_1772140700.xml · nonDerivative · entry 1 Bhatt Padmanabh P. · CIK 0001539215 · Sr. VP of IP, CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,694 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 16:57 UTC |
NEWHALL CHARLES W IIIDirector
|
Disposition to issuerRestricted Stock Unit · Derivative | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001005544-26-000004 · wk-form4_1772056655.xml · derivative · entry 2 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,475 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F2 · derivative.exercise_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. F2 · derivative.expiration_date: These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 16:57 UTC |
NEWHALL CHARLES W IIIDirector
|
GrantCommon Stock | 4,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001005544-26-000004 · wk-form4_1772056655.xml · nonDerivative · entry 1 NEWHALL CHARLES W III · CIK 0001005544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,119 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · derivative · entry 9 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 1,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F5 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. F5 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · derivative · entry 8 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F4 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. F4 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Disposition to issuerRestricted Stock Unit · Derivative | 1,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · derivative · entry 7 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 1,125 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. F3 · derivative.exercise_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. F3 · derivative.expiration_date: These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 671 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · nonDerivative · entry 6 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,766 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
GrantCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · nonDerivative · entry 5 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,437 Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:51 UTC |
Rubin JonathanSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 369 | $50.86 | $18,767.34 |
DisclosureSEC source: 0001836067-26-000004 · wk-form4_1772056270.xml · nonDerivative · entry 4 Rubin Jonathan · CIK 0001836067 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,187 F1 · shares: Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.